Stealth BioTherapeutics is looking to put its tumultuous path behind it with a new name. That new name is mighty—literally, as the biopharma is now Mighty Therapeutics, reflecting its recent change ...
Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...
TalesWorlds Entertainment has finally pushed out Mount & Blade 2: Bannerlord’s big naval-themed update on consoles on June 17! Players will be able to download this patch as version 1.34/1.035, and as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results